Sterling Pharma Solutions
Mitchell Vonderau is a seasoned professional in commercial operations and project management, currently serving as Senior Manager of Commercial Operations at Sterling Pharma Solutions since April 2019. Before this role, Mitchell held the position of Project Manager at CiVentiChem and gained experience as a Clinical Monitoring Associate at PAREXEL, where responsibilities included conducting site start-up activities and ensuring protocol adherence. Earlier in the career, Mitchell worked as a Clinical Research Associate at Cook Research Incorporated, facilitating study plan adherence and supporting research staff. Mitchell holds an MBA from Wake Forest University Graduate School and a Bachelor of Arts in Biology and Economics from DePauw University.
This person is not in any teams
This person is not in any offices
Sterling Pharma Solutions
1 followers
Sterling Pharma Solutions has over 50 years' experience serving the global pharmaceutical industry. Our facilities are located in Cramlington and Newcastle Biosphere, UK; Deeside, Wales; Cork, Ireland, as well as North Carolina and Wisconsin in the US. Our state-of-the-art facilities, proprietary technologies and experienced people are among the best in the industry. We have a proven track record in the supply of chemistry and analytical services across the entire product lifecycle, from grams to tonnes, from pre-clinical to commercial supply. Our world-class safety and quality standards are globally recognised and demonstrated through successful MHRA and FDA inspections and CIA Gold Awards for Safety the last three consecutive years. We pride ourselves on our customer focus and service approach, offering flexible, tailored solutions to our customers. In addition, our North Carolina and Newcastle Biosphere facilities offer expert chemistry solutions for small volume batches or products in the early stages of clinical trials. Our Deeside, Wales facility provide bioconjugation development services and specialised in antibody drug conjugation (ADC) research and development. Find out more: www.sterlingpharmasolutions.com/sterling-facilities